Comparative Activities of the Oxazolidinone AZD2563 and Linezolid against Selected Recent North American Isolates of Streptococcus pneumoniae
AUTOR(ES)
Baum, Sue E.
FONTE
American Society for Microbiology
RESUMO
The activity of AZD2563 against 250 highly resistant pneumococci and 267 drug-susceptible isolates was determined. The AZD2563 MICs for 50 and 90% of the strains tested were 1 and 2 μg/ml and 0.5 and 1 μg/ml, respectively, for the two isolate groups. These MICs were within 1 log2 dilution of those of linezolid.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=127405Documentos Relacionados
- In Vitro Activity of the New Oxazolidinone AZD2563 against Enterococci
- In Vitro Evaluation of AZD2563, a Novel Oxazolidinone, against 603 Recent Staphylococcal Isolates
- Activities of Cethromycin and Telithromycin against Recent North American Isolates of Streptococcus pneumoniae
- Activity of Daptomycin against Recent North American Isolates of Streptococcus pneumoniae
- Activity of AZD2563, a Novel Oxazolidinone, against Staphylococcus aureus Strains with Reduced Susceptibility to Vancomycin or Linezolid
